Company: MAGH
Filing Date: 2025-06-10
Form Type: F-1/A
Source: 0001641172-25-014489
Chunk: 37

Company: Magnitude International Ltd
Filing Date: 2025-06-10
Form: F-1/A
Chunk 37
---
 increased pressure to reduce our fees as our clients may reduce their demand for our services. If we lose significant fee volume or reduce the level of our fees significantly, then there could be a negative impact on our consolidated financial condition or results of operations, profitability and cash flows.

Risks Relating to Our Ordinary Shares and This Offering

An active trading market for our Ordinary Shares may not be established or, if established, may not continue and the trading price for our Ordinary Shares may fluctuate significantly.

We cannot assure you that a liquid public market for our Ordinary Shares will be established. If an active public market for our Ordinary Shares does not occur following the completion of this offering, the market price and liquidity of our Ordinary Shares may be materially and adversely affected. The public offering price for our Ordinary Shares in this offering was determined by negotiation between us and the underwriter based upon several factors, and we can provide no assurance that the trading price of our Ordinary Shares after this offering will not decline below the public offering price. As a result, investors in our Ordinary Shares may experience a significant decrease in the value of their shares.

We may not maintain the listing of our Ordinary Shares on Nasdaq which could limit investors’ ability to make transactions in Ordinary Shares and subject us to additional trading restrictions.

In order to continue listing our shares on Nasdaq, we must maintain certain financial and share price levels and we may be unable to meet these requirements in the future. We cannot assure you that our shares will continue to be listed on Nasdaq in the future.

If Nasdaq delists our Ordinary Shares and we are unable to list our shares on another national securities exchange, we expect our shares could be quoted on an over-the-counter market in the United States. If this were to occur, we could face significant material adverse consequences, including:

| ● | a                                                                                          
 limited availability of market quotations for our Ordinary Shares;                         |
| ● | reduced                                                                                    
 liquidity for our Ordinary Shares;                                                         |
| ● | a                                                                                          
 determination that our Ordinary Shares are “penny stock”, which will require               
 brokers trading in our shares to adhere to more stringent rules and possibly result in a   
 reduced level of trading activity in the secondary trading market for our ordinary shares; |

| 26 |

| ● | a                                                                                              
 limited amount of news and analyst coverage; and                                               |
| ● | a                                                                                              
 decreased ability to issue additional securities or obtain additional financing in the future. |

As long as our Ordinary Shares are listed on Nasdaq, U.S. federal law prevents or